No pain, no gain? Adverse effects of psychotherapy in obsessive-compulsive disorder and its relationship to treatment gains

Journal of Obsessive-Compulsive and Related Disorders

Volumn 5, Issue , 2015, Pages 61-66

  Moritz, Steffen ^a   Fieker, Martina ^a   Hottenrott, Birgit ^a   Seeralan, Tharanya ^a   Cludius, Barbara ^a   Kolbeck, Katharina ^a   Gallinat, Jürgen ^a   Nestoriuc, Yvonne ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Adverse events; Obsessive compulsive disorder; Psychotherapy; Side effects; Unwanted effects; Wanted effects

Indexed keywords

ADULT; AMBIVALENCE; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DETERIORATION; EXPOSURE THERAPY; FEMALE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MALPRACTICE; MEDICAL ETHICS; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; TREATMENT RESPONSE;

EID: 84924557406     PISSN: 22113649     EISSN: 22113657     Source Type: Journal    
DOI: 10.1016/j.jocrd.2015.02.002     Document Type: Article

References (29)

1. Abramowitz J.S., Deacon B.J. Psychometric properties and construct validity of the Obsessive-Compulsive Inventory - Revised: replication and extension with a clinical sample. Journal of Anxiety Disorders 2006, 20:1016-1035.
2. Barlow D.H. Negative effects from psychological treatments: a perspective. American Psychologist 2010, 65:13-20.
3. Beauregard M. Mind does really matter: evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Progress in Neurobiology 2007, 81:218-236.
4. Beaven D.W. Alternative medicine a cruel hoax - your money and your life?. The New Zealand Medical Journal 1989, 102:416-417.
5. Coles M.E., Cook L.M., Blake T.R. Assessing obsessive compulsive symptoms and cognitions on the internet: evidence for the comparability of paper and Internet administration. Behavior Research and Therapy 2007, 45:2232-2240.
6. Foa E.B., Huppert J.D., Leiberg S., Langner R., Kichic R., Hajcak G., et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychological Assessment 2002, 14:485-496.
7. Foa E.B., Zoellner L.A., Feeny N.C., Hembree E.A., Alvarez-Conrad J. Does imaginal exposure exacerbate PTSD symptoms?. Journal of Consulting and Clinical Psychology 2002, 70:1022-1028.
8. Food and Drug Administration Current good manufacturing practice regulation and investigational new drugs. Federal Register 2006, 71:2458-2462.
9. Gaudiano B.A., Herbert J.D. Can we really tap our problems away? A critical analysis of thought field therapy. Skeptical Inquirer 2000, 24:29-36.
10. Gumz A., Kastner D., Geyer M., Wutzler U., Villmann T., Brahler E. Instability and discontinuous change in the experience of therapeutic interaction: an extended single-case study of psychodynamic therapy processes. Psychotherapy Research 2010, 20:398-412.
11. Hatfield D., McCullough L., Frantz SH, Krieger K. Do we know when our clients get worse? An investigation of therapists[U+05F3] ability to detect negative client change. Clinical Psychology and Psychotherapy 2010, 17:25-32.
12. Haupt M.-L., Linden M., Strauß B. Definition und Klassifikation von Psychotherapie-Nebenwirkungen [Definition and classification of side-effects of psychotherapy]. Risiken und Nebenwirkungen von Psychotherapie 2012, 1-14. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin. M. Linden, B. Strauß (Eds.).
13. Hawkridge S.M., Stein D.J. A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescents. Drug Safety 1998, 19:283-297.
14. Holden W., Joseph J. Interactions between herbal remedies and antirheumatic drugs. Expert Opinion on Drug Safety 2005, 4:969-974.
15. Horne R., Cooper V., Gellaitry G., Date H.L., Fisher M. Patients[U+05F3] perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. Journal of Acquired Immune Deficiency Syndromes 2007, 45:334-341.
16. Ladwig I., Rief W., Nestoriuc Y Welche Risiken und Nebenwirkungen hat Psychotherapie? - Entwicklung des Inventars zur Erfassung Negativer Effekte von Psychotherapie (INEP) [What are the risks and side effects to psychotherapy? - Development of an Inventory for the assessment of Negative Effects of Psychotherapy (INEP)]. Verhaltenstherapie 2014, 24:252-263.
17. Lilienfeld S.O. Psychological treatments that cause harm. Perspectives on Psychological Science 2007, 2:53-70.
18. Linden D.E. Brain imaging and psychotherapy: methodological considerations and practical implications. European Archives of Psychiatry and Clinical Neuroscience 2008, 258(Suppl 5):S71-S75.
19. Linden M. How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clinical Psychology and Psychotherapy 2013, 20:286-296.
20. March J.S., Klee B.J., Kremer C.M. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. Journal of Child and Adolescent Psychopharmacology 2006, 16:91-102.
21. Messina I., Sambin M., Palmieri A., Viviani R. Neural correlates of psychotherapy in anxiety and depression: a meta-analysis. PLoS One 2013, 8:e74657.
22. Moritz S., Russu R. Further evidence for the efficacy of association splitting in obsessive-compulsive disorder. An internet study in a Russian-speaking sample. Journal of Obsessive-Compulsive and Related Disorders 2013, 2:91-98.
23. Moritz S., Timpano K.R., Wittekind C.E., Knaevelsrud C. Harnessing the web: Internet and self-help therapy for people with obsessive-compulsive disorder and post-traumatic stress disorder. Handbook of treating variants and complications in anxiety disorders 2013, 375-397. Springer, Heidelberg. E. Storch, D. McKay (Eds.).
24. Moritz S., Van Quaquebeke N., Hauschildt M., Jelinek L., Gönner S. Good news for allegedly bad studies. Assessment of psychometric properties may help to elucidate deception in online studies on OCD. Journal of Obsessive-Compulsive and Related Disorders 2012, 1:331-335.
25. Moritz S., Wittekind C.E., Hauschildt M., Timpano K.R. Do it yourself? Self-help and online therapy for people with obsessive-compulsive disorder. Current Opinion in Psychiatry 2011, 24:541-548.
26. Nestoriuc Y., Rief W. Nebenwirkungen von Verhaltenstherapie [Side-effects of behavior therapy]. Risiken und Nebenwirkungen von Psychotherapie 2012, 59-74. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin. M. Linden, B. Strauß (Eds.).
27. Nutt D.J., Sharpe M. Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. Journal of Psychopharmacology 2008, 22:3-6.
28. Olatunji B.O., Deacon B.J., Abramowitz J.S. The cruelest cure? Ethical issues in the implementation of exposure-based treatments. Cognitive and Behavioral Practice 2009, 16:172-180.
29. Quide Y., Witteveen A.B., El-Hage W., Veltman D.J., Olff M. Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neuroscience and Biobehavioral Reviews 2012, 36:626-644.